Open-label, Randomized, Multi-center, Parallel Group, Two-arm Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir vs Standard of Care for Trtmt of Adenovirus Infections in High-risk Pediatric Allo HCT Recipients